Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 1/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.49 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.49 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1222870 | 0.87 | SLC9A1 (0.67) | SLC9A1CYP1A2CYP2C19KDM4EALDH1A1 | |
| SCHEMBL11806267 | 0.85 | CYP1A2 (0.68) | SLC9A1CYP1A2CYP2C19KDM4EALDH1A1 | |
| SCHEMBL5842720 | 0.85 | SLC9A1 (0.74) | SLC9A1CYP1A2CYP2C19KDM4EALDH1A1 | |
| SCHEMBL1199181 | 0.83 | CYP1A2 (0.77) | SLC9A1CYP1A2CYP2C19KDM4EALDH1A1 | |
| SCHEMBL13044117 | 0.82 | CYP1A2 (0.71) | SLC9A1CYP1A2CYP2C19KDM4EALDH1A1 | |
| SCHEMBL9877550 | 0.82 | CYP1A2 (0.71) | SLC9A1CYP1A2CYP2C19KDM4EALDH1A1 | |
| SCHEMBL29353751 | 0.80 | NR4A1 (0.74) | SLC9A1GAANR4A1NR4A2NR4A3 | |
| SCHEMBL28202474 | 0.80 | NR4A1 (0.74) | SLC9A1GAANR4A1NR4A2NR4A3 | |
| SCHEMBL19657014 | 0.79 | SLC9A1 (0.66) | SLC9A1CYP1A2CYP2C19KDM4EALDH1A1 | |
| SCHEMBL3059961 | 0.78 | SLC9A1 (0.65) | SLC9A1CYP1A2CYP2C19KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024196978-A2 | SULFONIUM COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2024-09-26 | — | — | WO | disclosed |
| US-20100130483-A1 | NOVEL DIAZABICYCLIC ARYL DERIVATIVES | NEUROSEARCH A/S (DK) | 2010-05-27 | — | — | US | disclosed |
| US-7678788-B2 | Diazabicyclic aryl derivatives | NEUROSEARCH A/S (DK) | 2010-03-16 | — | — | US | disclosed |
| EP-1599476-B1 | NOVEL DIAZABICYCLIC ARYL DERIVATIVES | NEUROSEARCH AS (DK) | 2009-10-14 | — | — | EP | disclosed |
| US-20060148789-A1 | Novel diazabicyclic aryl derivatives | NEUROSEARCH A/S (DK) | 2006-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100130483-A1 | NOVEL DIAZABICYCLIC ARYL DERIVATIVES | CHRNA6, CHRNA10, CHRNA2 | SLC9A1 3488/4885CYP1A2 1095/4885CYP2C19 1815/4885 |
| US-20060148789-A1 | Novel diazabicyclic aryl derivatives | CHRNA6, CHRNA10, CHRNA2 | SLC9A1 3488/4885CYP1A2 1095/4885CYP2C19 1815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.